Portal de investigação
Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Recchiuti, A
- Isopi, E
- Verri, W
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1664-042X, 1664-042X
- Tipo:
- Editorial Material
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
Frontiers in Physiology Frontiers Media S.A.
Documentos
- Não há documentos
Filiações
Keywords
- specialized proresolving lipid mediators; inflammation; cardiometabolic disorders; neurological diseases; psychiatric disease
Financiamento
Proyectos asociados
Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and therapeutic targets. (severe COVID-19)
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Severe COVID-19) . FCT . 2020
Endocan: a novel biomarker for risk stratification, prognosis, and therapeutic monitoring in human cardiovascular and renal diseases
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Endocan) . 2020
Renal renin-angiotensin system activation in acute heart failure and its association with endothelial dysfunction, inflammation and oxidative stress.
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico (Renal) . 2021
Urinary cysteinyl leukotrienes as biomarkers of endothelial activation, inflammation and oxidative stress and their relationship with organ dysfunction in human septic shock
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2021
Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Endothelial dysfunction in different stages of diseases severity of COVID-19: focus on endocan and arterial hypertension
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients
Investigador Principal: Teresa Maria de Jesus Teixeira de Sousa
Estudo Clínico Académico . 2022
Citar a publicação
Sousa T,Pinho D,Recchiuti A,Isopi E,Verri W. Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders. Front. Physiol. 2023. 141176700. IF:4,000. (2).
